RemSleep Holdings (RMSL) Assets Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | RemSleep Holdings | - | - | -7,636.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.05% |
| Sep 30, 2025 | 15.57% |
| Jun 30, 2025 | 25.59% |
| Mar 31, 2025 | 9.92% |
| Dec 31, 2024 | 18.49% |
| Sep 30, 2024 | 32.65% |
| Jun 30, 2024 | 31.32% |
| Mar 31, 2024 | 59.25% |
| Dec 31, 2023 | 84.08% |
| Sep 30, 2023 | 92.74% |
| Jun 30, 2023 | 59.88% |
| Mar 31, 2023 | 90.88% |
| Dec 31, 2022 | 78.83% |
| Sep 30, 2022 | 234.50% |
| Jun 30, 2022 | 191.63% |
| Mar 31, 2022 | 219.61% |
| Dec 31, 2021 | 206.93% |
| Sep 30, 2021 | 167.72% |
| Jun 30, 2021 | 90.89% |
| Mar 31, 2021 | 72.01% |
| Dec 31, 2020 | 64.98% |
| Sep 30, 2020 | 63.98% |
| Jun 30, 2020 | 55.26% |
| Mar 31, 2020 | 79.66% |
| Dec 31, 2019 | 69.65% |
| Sep 30, 2018 | 499.65% |
| Jun 30, 2018 | 334.41% |
| Mar 31, 2018 | 178.84% |
| Dec 31, 2017 | 228.83% |
| Sep 30, 2017 | 66.67% |
| Jun 30, 2017 | -7.84% |
| Mar 31, 2017 | 4.98% |
| Dec 31, 2016 | 0.77% |
| Sep 30, 2016 | -20.42% |
| Jun 30, 2016 | 11.24% |
| Dec 31, 2015 | 11.91% |